Login

Insider Transactions

What VALEANT PHARMACEUTICALS INTERNATIONAL's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Ubben Jeffrey W Director May 26 Withheld — tax / exercise cost · F −124 $224.63 −$27.9K 3,117
Ubben Jeffrey W Director May 22 Grant / award · A +1,607 — — 3,241
Provencio Norma Ann Director Sep 28 Disposition to Issuer · D −39,574 — — 0
ValueAct Holdings, L.p. 10% owner Sep 28 Disposition to Issuer · D −15,138,358 — — 0
ValueAct Holdings, L.p. 10% owner Sep 28 Disposition to Issuer · D −24,687 — — 0
Chaudhuri Bhaskar President Sep 28 Disposition to Issuer · D −333,438 — — 0
Karlson Elisa A. EVP, Chief Admin Officer Sep 28 Disposition to Issuer · D −218,663 — — 0
Pearson J. Michael CEO and Chairman Sep 28 Disposition to Issuer · D −1,931,505 — — 0
Min Steve T. EVP, General Counsel Sep 28 Disposition to Issuer · D −213,069 — — 0
Blott Peter J EVP, Chief Financial Officer Sep 28 Disposition to Issuer · D −216,889 — — 0
De Silva Rajiv Chief Operating Officer Sep 28 Disposition to Issuer · D −261,994 — — 0
Stefano Stephen F. Director Sep 28 Disposition to Issuer · D −10,902 — — 0
Lonner Anders Director Sep 28 Disposition to Issuer · D −12,766 — — 0
Melas Kyriazi Theo Director Sep 28 Disposition to Issuer · D −60,627 — — 0
Ingram Robert A Director Sep 28 Disposition to Issuer · D −79,053 — — 0
Koppes Richard Director Sep 28 Disposition to Issuer · D −54,523 — — 0
Kugelman Larry Director Sep 28 Disposition to Issuer · D −55,589 — — 0
Morfit G Mason Director Sep 28 Disposition to Issuer · D −24,687 — — 0
De Silva Rajiv Chief Operating Officer Aug 24 Withheld — tax / exercise cost · F −1,343 $57.02 −$76.6K 94,101
De Silva Rajiv Chief Operating Officer Aug 24 Withheld — tax / exercise cost · F −1,044 $57.02 −$59.5K 95,444

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support